metricas

Acta Colombiana de Cuidado Intensivo

Sugerencias
Acta Colombiana de Cuidado Intensivo Estado hiperglucémico hiperosmolar: Enfoque práctico para el diagnóstico y tr...
Información de la revista
Vol. 26. Núm. 3.
(Julio - Septiembre 2026)
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Visitas
42029
Vol. 26. Núm. 3.
(Julio - Septiembre 2026)
Revisión

Estado hiperglucémico hiperosmolar: Enfoque práctico para el diagnóstico y tratamiento basado en guías

Hyperosmolar hyperglycemic state: A practical approach to guideline-based diagnosis and treatment
Visitas
42029
José Correa-Guerreroa,c,
Autor para correspondencia
josegabriel2101@gmail.com

Autor para correspondencia.
, Elguis Rodríguez Garizabalob, Jesús Bello Simancac, Hugo Corrales Santanderd, Francisco Camargo Assise, Luis Rodríguez Arrietaf, Alejandro Castellano Pinedog, Carmelo Dueñas Castellh,c
a Critical and Internal Medicine Research Group (CRITIMED), Cartagena de Indias, Colombia
b Departamento de Medicina Interna, Universidad Simón Bolívar, Barranquilla, Colombia
c Departamento Médico, Universidad de Cartagena, Cartagena de Indias, Colombia
d Departamento de Endocrinología, Neurum IPS-Centro de especialistas, Medellín, Colombia
e Departamento de Medicina Crítica y Cuidado Intensivo, Clínica Zayma, Montería, Colombia
f Departamento de Endocrinología, Hospital Alma Mater, Medellín, Colombia
g Departamento de Endocrinología, Hospital San Jerónimo, Montería, Colombia
h Grupo de Investigación en Cuidados Intensivos y Obstetricia (GRICIO), Cartagena de Indias, Colombia
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Resumen

El estado hiperosmolar hiperglucémico es una complicación metabólica grave caracterizada por hiperglucemia intensa, deshidratación y elevada osmolaridad plasmática, con alta mortalidad, especialmente en adultos mayores y en pacientes con comorbilidades. Su manejo óptimo incluye reposición hídrica vigilada, insulinoterapia titulada, monitorización estrecha de electrólitos y prevención de complicaciones terapéuticas. Esta revisión se centra en la evolución de los criterios diagnósticos y las estrategias terapéuticas actuales, basadas en guías y consensos internacionales. Se realizó una búsqueda manual en los sitios web oficiales de la American Diabetes Association, la American Association of Clinical Endocrinologists y la Joint British Diabetes Societies, complementada con bases de datos como PubMed/MEDLINE, Scopus y ScienceDirect para bibliografía primaria derivada. Dado el carácter narrativo de la revisión, no se utilizó una herramienta estructurada para evaluar formalmente la calidad metodológica de las guías incluidas; en su lugar, se realizó una valoración cualitativa basada en la consistencia de las recomendaciones y su aplicabilidad clínica. Esta aproximación priorizó la utilidad práctica y la comparación conceptual entre consensos por encima de una evaluación metodológica exhaustiva.

Palabras clave:
Estado hiperglucémico hiperosmolar
Crisis hiperglucémica
Diagnóstico
Fluidoterapia
Insulinoterapia
Abstract

Hyperosmolar hyperglycemic state is a severe metabolic complication characterized by marked hyperglycemia, dehydration, and elevated plasma osmolality, with high mortality, especially among older adults and patients with comorbidities. Optimal management includes carefully monitored fluid replacement, titrated insulin therapy, close electrolyte monitoring, and prevention of treatment-related complications. This review focuses on the evolution of diagnostic criteria and current therapeutic strategies based on international guidelines and consensus statements. A manual search was conducted on the official websites of the American Diabetes Association, the American Association of Clinical Endocrinologists, and the Joint British Diabetes Societies, complemented by databases such as PubMed/MEDLINE, Scopus, and ScienceDirect for related primary literature. Given the narrative nature of this review, no structured tool was used to formally assess the methodological quality of the included guidelines; instead, a qualitative appraisal was performed based on the consistency of the recommendations and their clinical applicability. This approach prioritized practical usefulness and conceptual comparison among consensus statements over an exhaustive methodological evaluation.

Keywords:
Hyperosmolar hyperglycemic state
Hyperglycemic crisis
Diagnosis
Fluid therapy
Insulin therapy

Artículo

Opciones para acceder a los textos completos de la publicación Acta Colombiana de Cuidado Intensivo
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Bibliografía
[1]
F.J. Pasquel, G.E. Umpierrez.
Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment.
Diabetes Care., 37 (2014), pp. 3124-3131
[2]
S.S. Lovegrove, S.B. Dubbs.
Hyperosmolar hyperglycemic state.
Emerg Med Clin N Am., 41 (2023), pp. 687-696
[3]
G.E. Umpierrez, G.M. Davis, N.A. ElSayed, et al.
Hyperglycemic crises in adults with diabetes: a consensus report.
Diabetes Care., 47 (2024), pp. 1257-1275
[4]
Federación Internacional de Diabetes (IDF). Atlas de la diabetes [Internet]. 11.ª edición. Bruselas: Federación Internacional de Diabetes; 2025. Disponible en: https://diabetesatlas.org/es/resources/idf-diabetes-atlas-2025/.
[5]
F.J. Pasquel, K. Tsegka, H. Wang, et al.
Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: a retrospective hospital-based cohort study.
Diabetes Care., 43 (2020),
[6]
E.V. Rosager, A.L.K. Heltø, C.U. Fox Maule, et al.
Incidence and characteristics of the hyperosmolar hyperglycemic state: a Danish cohort study.
Diabetes Care., 47 (2024), pp. 272-279
[7]
H. Shaka, Z. El-amir, F.ET-AL> Wani.
Hospitalizations and inpatient mortality for hyperosmolar hyperglycemic state over a decade.
Diabetes Res Clin Pract, 185 (2022), pp. 109230
[8]
B. Shvarts, E. Golbets, I. Sagy, et al.
Is our understanding of hyperosmolar hyperglycemic state accurate?.
J Emerg Med, 79 (2025), pp. 531-538
[9]
M. Fayfman, F.J. Pasquel, G.E. Umpierrez.
Management of hyperglycemic crises.
Med Clin N Am., 101 (2017), pp. 587-606
[10]
G. Umpierrez, M. Korytkowski.
Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.
Nat Rev Endocrinol., 12 (2016), pp. 222-232
[11]
E. Karslioglu French, A.C. Donihi, M.T. Korytkowski.
Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients.
BMJ, (2019),
[12]
A.E. Kitabchi, E.A. Nyenwe.
Hyperglycemic crises in diabetes mellitus: diabetic ketoacidosis and hyperglycemic hyperosmolar State.
Endocrinol Metabol Clin N Am, 35 (2006), pp. 725-751
[13]
D.R. Wilson, L. D'Souza, N. Sarkar, M. Newton, C. Hammond.
New-onset diabetes and ketoacidosis with atypical antipsychotics.
Schizophr Res., 59 (2003), pp. 1-6
[14]
C. Ekpebegh, B. Longo-Mbenza.
Mortality in hyperglycemic crisis: a high association with infections and cerebrovascular disease.
Minerva Endocrinol., 38 (2013), pp. 187-193
[15]
S.A. Tavakoli, M.S. Arguisola.
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
[16]
O.G. Mustafa, M. Haq, U. Dashora, E. Castro, K.K. Dhatariya, the Joint British Diabetes Societies (JBDS) for Inpatient Care Group.
Management of hyperosmolar hyperglycaemic state (HHS) in adults: an updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group.
Diabet Med., 40 (2023), pp. e15005
[17]
A.E. Kitabchi, G.E. Umpierrez, J.M. Miles, J.N. Fisher.
Hyperglycemic crises in adult patients with diabetes.
Diabetes Care., 32 (2009), pp. 1335-1343
[18]
B. Gershkovich, S.W. English, M.A. Doyle, K. Menon, L. McIntyre.
Choice of crystalloid fluid in the treatment of hyperglycemic emergencies: a systematic review protocol.
[19]
A.E. Kitabchi, G.E. Umpierrez, M.B. Murphy, et al.
Management of hyperglycemic crises in patients with diabetes.
Diabetes Care., 24 (2001), pp. 131-153
[20]
N.M. Yunos, R. Bellomo, C. Hegarty, D. Story, L. Ho, M. Bailey.
Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults.
[21]
M.W. Semler, W.H. Self, J.P. Wanderer, et al.
Balanced crystalloids versus saline in critically ill adults.
N Engl J Med., 378 (2018), pp. 829-839
[22]
S.A. McCluskey, K. Karkouti, D. Wijeysundera, L. Minkovich, G. Tait, W.S. Beattie.
Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study.
Anesth Analg., 117 (2013), pp. 412-421
[23]
N.A. Alghamdi, P. Major, D. Chaudhuri, et al.
Saline compared to balanced crystalloid in patients with diabetic ketoacidosis: a systematic review and meta-analysis of randomized controlled trials.
Crit Care Explor., 4 (2022), pp. e0613
[24]
W.H. Self, C.S. Evans, C.A. Jenkins, et al.
Clinical effects of balanced crystalloids vs saline in adults with diabetic ketoacidosis: a subgroup analysis of cluster randomized clinical trials.
JAMA Netw Open., 3 (2020), pp. e2024596
[25]
J.A. Catahay, E.T. Polintan, M. Casimiro, et al.
Balanced electrolyte solutions versus isotonic saline in adult patients with diabetic ketoacidosis: A systematic review and meta-analysis.
Heart Lung, 54 (2022), pp. 74-79
[26]
A. Jahangir, A. Jahangir, F.S. Siddiqui, et al.
Normal saline versus low chloride solutions in treatment of diabetic ketoacidosis: a systematic review of clinical trials.
Cureus [Internet]., (2022),
[27]
A. Acheampong, J.L. Vincent.
A positive fluid balance is an independent prognostic factor in patients with sepsis.
Crit Care., 19 (2015), pp. 251
[28]
J.H. Boyd, J. Forbes, Nakada T aki, K.R. Walley, J.A. Russell.
Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality*.
Crit Care Med., 39 (2011), pp. 259-265
[29]
T.S. Meyhoff, P.B. Hjortrup, J. Wetterslev, et al.
Restriction of intravenous fluid in ICU patients with septic shock.
N Engl J Med., 386 (2022), pp. 2459-2470
[30]
N.I. Shapiro, I.S. Douglas, R.G. Brower, The National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network, et al.
Early restrictive or liberal fluid management for sepsis-induced hypotension.
N Engl J Med., 388 (2023), pp. 499-510
[31]
R.J. Galindo, F.J. Pasquel, M. Fayfman, et al.
Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis.
BMJ Open Diab Res Care., 8 (2020), pp. e000763
[32]
P. Zeitler, A. Haqq, A. Rosenbloom, N. Glaser.
Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment.
J Pediatr, 158 (2011), pp. 9-14.e2
[33]
G.E. Umpierrez, S. Jones, D. Smiley, et al.
Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis.
Diabetes Care., 32 (2009), pp. 1164-1169
[34]
R.C. Ross, N.S. Vadakkel, K. Westmoreland, et al.
Risk factors for hypoglycemia during treatment of hyperglycemic crises.
Diabetes Spectr, 35 (2022), pp. 484-490
[35]
M.L. Malone, S.E. Klos, V.M. Gennis, J.S. Goodwin.
Frequent hypoglycemic episodes in the treatment of patients with diabetic ketoacidosis.
Arch Intern Med., 152 (1992), pp. 2472-2477
[36]
T. González-Vidal, C. Lambert, A.V. García, et al.
Hypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality.
Diabetol Metab Syndr., 16 (2024), pp. 83
[37]
P. English, G. Williams.
Hyperglycaemic crises and lactic acidosis in diabetes mellitus.
Postgrad Med J, 80 (2004), pp. 253-261
[38]
O. Paltiel, E. Salakhov, I. Ronen, D. Berg, A. Israeli.
Management of severe hypokalemia in hospitalized patients: a study of quality of care based on computerized databases.
Arch Intern Med., 161 (2001), pp. 1089
[39]
K. Murthy, J.T. Harrington, R.D. Siegel.
Profound hypokalemia in diabetic ketoacidosis: a therapeutic challenge.
Endocrine Pract., 11 (2005), pp. 331-334
[40]
A.E. Morales, A.L. Rosenbloom.
Death caused by hyperglycemic hyperosmolar state at the onset of type 2 diabetes.
J Pediatr, 144 (2004), pp. 270-273
[41]
S.A. Wani, M.S. Ahamed, J. Shruthi, R.M. Shariq.
A case report of SGLT2 inhibitor-associated diabetic ketoacidosis- hyperglycemic hyperosmolar state (DKA/HHS) overlap.
Clin Med Case Rep., 08 (2024), pp. 301
[42]
F.J. Pasquel, G.M. Davis, D.M. Huffman, et al.
Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial.
JAMA Netw Open., 8 (2025), pp. e2459348
asdasdasd
Opciones de artículo
Herramientas